FI933248A0 - Optiskt aktiva 5h-pyrrolo(3,4-b)pyrazinderat, dess framstaellning och farmaceutiska kompositioner innehaollande detta - Google Patents

Optiskt aktiva 5h-pyrrolo(3,4-b)pyrazinderat, dess framstaellning och farmaceutiska kompositioner innehaollande detta

Info

Publication number
FI933248A0
FI933248A0 FI933248A FI933248A FI933248A0 FI 933248 A0 FI933248 A0 FI 933248A0 FI 933248 A FI933248 A FI 933248A FI 933248 A FI933248 A FI 933248A FI 933248 A0 FI933248 A0 FI 933248A0
Authority
FI
Finland
Prior art keywords
pyrazinderat
detta
pyrrolo
pharmaceutical composition
optical active
Prior art date
Application number
FI933248A
Other languages
English (en)
Other versions
FI100331B (fi
FI933248A (fi
Inventor
Claude Cotrel
Gerard Roussel
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9408772&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI933248(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI933248A publication Critical patent/FI933248A/fi
Publication of FI933248A0 publication Critical patent/FI933248A0/fi
Application granted granted Critical
Publication of FI100331B publication Critical patent/FI100331B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI933248A 1991-01-17 1993-07-16 Menetelmä terapeuttisesti aktiivisen (+)-6-(5-kloori-2-pyridyyli)-5-(4 -metyyli-1-piperatsinyyli)karbonyylioksi-7-okso-6,7-dihydro-5H-pyrrolo £3,4-b|pyratsiinin valmistamiseksi FI100331B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9100490A FR2671800B1 (fr) 1991-01-17 1991-01-17 Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent.
FR9100490 1991-01-17
FR9200031 1992-01-06
PCT/FR1992/000031 WO1992012980A1 (fr) 1991-01-17 1992-01-16 DERIVE DE LA 5H-PYRROLO[3,4-b]PYRAZINE OPTIQUEMENT ACTIF, SA PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LE CONTIENNENT

Publications (3)

Publication Number Publication Date
FI933248A FI933248A (fi) 1993-07-16
FI933248A0 true FI933248A0 (fi) 1993-07-16
FI100331B FI100331B (fi) 1997-11-14

Family

ID=9408772

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933248A FI100331B (fi) 1991-01-17 1993-07-16 Menetelmä terapeuttisesti aktiivisen (+)-6-(5-kloori-2-pyridyyli)-5-(4 -metyyli-1-piperatsinyyli)karbonyylioksi-7-okso-6,7-dihydro-5H-pyrrolo £3,4-b|pyratsiinin valmistamiseksi

Country Status (29)

Country Link
US (5) US6319926B1 (fi)
EP (2) EP0609210B1 (fi)
JP (1) JPH06504548A (fi)
AR (1) AR248024A1 (fi)
AT (1) ATE121089T1 (fi)
AU (2) AU671797B2 (fi)
CA (1) CA2099782C (fi)
CZ (1) CZ281011B6 (fi)
DE (1) DE69202060T2 (fi)
DK (1) DK0609210T3 (fi)
ES (1) ES2071486T3 (fi)
FI (1) FI100331B (fi)
FR (1) FR2671800B1 (fi)
HU (1) HU218928B (fi)
IE (1) IE66110B1 (fi)
IL (1) IL100677A (fi)
MA (1) MA22392A1 (fi)
MX (1) MX9200180A (fi)
NO (1) NO179911C (fi)
NZ (1) NZ241313A (fi)
OA (1) OA09807A (fi)
PH (1) PH30982A (fi)
PL (1) PL166976B1 (fi)
RU (1) RU2110519C1 (fi)
SK (1) SK279060B6 (fi)
TN (1) TNSN92004A1 (fi)
WO (1) WO1992012980A1 (fi)
YU (1) YU48878B (fi)
ZA (1) ZA92302B (fi)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671800B1 (fr) 1991-01-17 1993-03-12 Rhone Poulenc Rorer Sa Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent.
US5786357A (en) 1991-12-02 1998-07-28 Sepracor Inc. Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone
ES2101653B1 (es) * 1995-07-10 1998-04-01 Asturpharma S A (+)-6-(5-cloropirid-2-il)-7-oxo-viniloxicarboniloxi-5,6-dihidropirrolo(3,4b)pirazina y su uso para un procedimiento de preparacion de (+)-6-(5-cloropirid-2-il)-5-(4-metilpiperazin-1-il)-carboniloxi-7-oxo-5,6-dihidropirrolo(3,4b)pirazina.
US6339086B1 (en) * 1999-05-14 2002-01-15 Swpracor, Inc. Methods of making and using N-desmethylzopiclone
TW200734460A (en) 1999-10-04 2007-09-16 Ajinomoto Kk Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria
CA2548917C (en) 2003-12-11 2014-09-23 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
WO2005063248A1 (en) * 2003-12-22 2005-07-14 Sepracor Inc. Modafinil combination therapy for improving sleep quality
US20050164987A1 (en) * 2003-12-24 2005-07-28 Barberich Timothy J. Melatonin combination therapy for improving sleep quality
US20050267176A1 (en) * 2004-02-18 2005-12-01 Sepracor Inc. Dopamine-agonist combination therapy for improving sleep quality
AU2005231490B2 (en) * 2004-04-05 2011-05-19 Sunovion Pharmaceuticals Inc. Methods of treatment using eszopiclone
WO2006136866A1 (en) * 2005-06-21 2006-12-28 Generics [Uk] Limited Process for enantiomeric separation of zopiclone
CA2614209A1 (en) * 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and o-desmethylvenlafaxine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
JP2009500425A (ja) 2005-07-06 2009-01-08 セプラコア インコーポレーテッド エスゾピクロン及びトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−ｎ−メチル−１−ナフタレンアミン又はトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−１−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
US7476737B2 (en) * 2005-09-05 2009-01-13 Dr. Reddy's Laboratories Limited Eszopiclone process
US20070098788A1 (en) * 2005-10-28 2007-05-03 Gore Subhash P Non-benzodiazepine hypnotic compositions
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
EP1984368A2 (en) * 2006-01-17 2008-10-29 Glenmark Pharmaceuticals Limited Improved process for the preparation of an optically active 5h-pyrrolo [3,4-b]pyrazine derivative
WO2007088073A1 (en) * 2006-02-03 2007-08-09 Synthon B.V. Zopiclone resolution using l-tartaric acid
US20080027223A1 (en) * 2006-03-23 2008-01-31 Teva Pharmaceutical Industries Ltd. Polymorphs of eszopiclone malate
EP2007768A2 (en) * 2006-04-20 2008-12-31 Teva Pharmaceutical Industries Ltd Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone
WO2008002629A1 (en) * 2006-06-26 2008-01-03 Teva Pharmaceutical Industries Ltd. Process for the preparation of zopiclone
US7786304B2 (en) * 2006-11-06 2010-08-31 Centaur Pharmaceutical Pvt. Ltd. Process for the preparation of eszopiclone
US20080287447A1 (en) * 2007-01-31 2008-11-20 Nina Finkelstein Methods for preparing eszopiclone
ATE515259T1 (de) * 2007-05-29 2011-07-15 Lek Pharmaceuticals Pharmazeutische zusammensetzung mit eszopiclon
US20080305171A1 (en) * 2007-06-07 2008-12-11 Kristin Anne Arnold Pyrrolopyrazine, formulations, methods of manufacture, and methods of use there
US20090018336A1 (en) * 2007-06-25 2009-01-15 Nina Finkelstein Racemization process of R-zopiclone
EP2020403A1 (en) 2007-08-02 2009-02-04 Esteve Quimica, S.A. Process for the resolution of zopiclone and intermediate compounds
WO2009063486A2 (en) * 2007-08-06 2009-05-22 Usv Limited Process for preparation of dextrorotatory isomer of 6-(5-chloro-pyrid-2-yi)-5-[(4-methyl -1-piperazinyl) carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo [3,4-b] pyrazine (eszopiclone)
US8198278B2 (en) 2007-12-19 2012-06-12 Sunovion Pharmaceuticals Inc. Besylate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US8268832B2 (en) * 2007-12-19 2012-09-18 Sunovion Pharmaceuticals Inc. Maleate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US8269005B2 (en) * 2007-12-19 2012-09-18 Sunovion Pharmaceuticals Inc. L-malate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-Oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US8198277B2 (en) 2007-12-19 2012-06-12 Sunovion Pharmaceuticals Inc. L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US8212036B2 (en) * 2007-12-19 2012-07-03 Sunovion Pharmaceuticals Inc. Maleate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
CA2747000C (en) * 2007-12-19 2013-09-03 Sunovion Pharmaceuticals Inc. Maleate, besylate, and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine
WO2009085988A1 (en) * 2007-12-19 2009-07-09 Sepracor Inc. Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7- dihydro-5h-pyrrolo[3,4-b]pyrazine
WO2009101634A2 (en) * 2008-02-13 2009-08-20 Lupin Limited A novel process for the preparation of eszopiclone
US9616070B2 (en) * 2008-03-12 2017-04-11 Emory University Use of GABAA receptor antagonists for the treatment of excessive sleepiness and disorders associated with excessive sleepiness
US20090269409A1 (en) * 2008-04-24 2009-10-29 Mukesh Kumar Garg Pharmaceutical compositions comprising eszopiclone
CN101607961B (zh) * 2008-06-18 2011-08-10 天津天士力集团有限公司 一种右佐匹克隆结晶及其组合物
NZ592976A (en) 2008-11-07 2012-03-30 Cipla Ltd Process for resolving zopiclone
EP2370136A4 (en) * 2008-12-01 2015-12-30 Map Pharmaceuticals Inc INHALATIVE RELEASE PROCEDURES AND DEVICES
US8555875B2 (en) * 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
WO2010088385A1 (en) 2009-01-30 2010-08-05 Sepracor Inc. Coated tablets of 6-(5-chloro-2-pyridyl) -5-[ (4-methyl-1-piperazinyl) carbonyloxy]-7-oxo-6, 7-dihydro-5h-pyrrol o [3,4-b] pyrazine and methods for measuring effectiveness of coating
WO2010116385A2 (en) 2009-04-08 2010-10-14 Rubicon Research Private Limited Pharmaceutical compositions for alleviating unpleasant taste
EP2345654A1 (en) 2010-01-05 2011-07-20 LEK Pharmaceuticals d.d. Eszopiclone particles and a process for their preparation
EP2345655A1 (en) 2010-01-05 2011-07-20 LEK Pharmaceuticals d.d. A process for racemisation of 6-(5-chloropyridin-2-yl)-7-(4-methyl-1-piperazinyl)carbonyloxy-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
CN103193779B (zh) * 2012-01-05 2016-04-20 成都弘达药业有限公司 一种右佐匹克隆的制备方法
BR112015014775A2 (pt) * 2012-12-20 2017-07-11 Kashiv Pharma Llc formulação, comprimido de desintegração oral, e, método para o tratamento de um indivíduo
US9636340B2 (en) 2013-11-12 2017-05-02 Ayyappan K. Rajasekaran Kinase inhibitors
JP2020007252A (ja) * 2018-07-05 2020-01-16 アクティブファーマ株式会社 エスゾピクロンジベンゾイル−ｄ−酒石酸塩の製造方法、エスゾピクロンの製造方法、及びエスゾピクロンジベンゾイル−ｄ−酒石酸塩の結晶

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA04285A (fr) * 1972-01-07 1979-12-31 Rhone Poulenc Sa Nouveaux dérivés de la pyrrolo (3,4-b) pyrazine et leur préparation.
AR208414A1 (es) * 1974-11-07 1976-12-27 Rhone Poulenc Ind Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2)
US4962124A (en) 1987-11-17 1990-10-09 Analgesic Associates Onset-hastened/enhanced antipyretic response
US4868214A (en) 1987-11-17 1989-09-19 Analgesic Associates Onset-hastened/enhanced analgesia
US5102890A (en) 1989-09-05 1992-04-07 Rhone-Poulenc Sante Pyrrole derivatives, their preparation and pharmaceutical compositions which contain them
FR2671800B1 (fr) * 1991-01-17 1993-03-12 Rhone Poulenc Rorer Sa Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent.
AU3275993A (en) 1991-12-02 1993-06-28 Sepracor, Inc. Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (-) zopiclone
US5786357A (en) * 1991-12-02 1998-07-28 Sepracor Inc. Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone
US5331000A (en) 1992-03-09 1994-07-19 Sepracor Inc. Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
US6436926B1 (en) * 1999-05-10 2002-08-20 Medpointe, Inc. Compositions and methods for treating superficial fungal infections
US7476737B2 (en) * 2005-09-05 2009-01-13 Dr. Reddy's Laboratories Limited Eszopiclone process
WO2007088073A1 (en) * 2006-02-03 2007-08-09 Synthon B.V. Zopiclone resolution using l-tartaric acid

Also Published As

Publication number Publication date
ZA92302B (en) 1992-10-28
AR248024A1 (es) 1995-05-31
HU9302063D0 (en) 1993-10-28
DK0609210T3 (da) 1995-07-03
IL100677A0 (en) 1992-09-06
NO179911C (no) 1997-01-08
US20060194806A1 (en) 2006-08-31
NO931919L (no) 1993-05-26
SK71993A3 (en) 1993-12-08
US20020193378A1 (en) 2002-12-19
FI100331B (fi) 1997-11-14
FI933248A (fi) 1993-07-16
US6444673B1 (en) 2002-09-03
TNSN92004A1 (fr) 1993-06-08
EP0609210A1 (fr) 1994-08-10
CA2099782C (fr) 2002-12-03
CZ138093A3 (en) 1994-02-16
FR2671800B1 (fr) 1993-03-12
AU3032195A (en) 1995-11-09
PH30982A (en) 1997-12-23
IE66110B1 (en) 1995-12-13
DE69202060D1 (de) 1995-05-18
MX9200180A (es) 1992-07-01
AU671797B2 (en) 1996-09-12
EP0495717A1 (fr) 1992-07-22
HU218928B (hu) 2000-12-28
AU1226492A (en) 1992-08-27
YU48878B (sh) 2002-09-19
US6864257B2 (en) 2005-03-08
WO1992012980A1 (fr) 1992-08-06
SK279060B6 (sk) 1998-06-03
NO931919D0 (no) 1993-05-26
US20050043311A1 (en) 2005-02-24
CZ281011B6 (cs) 1996-05-15
JPH06504548A (ja) 1994-05-26
NO179911B (no) 1996-09-30
US7125874B2 (en) 2006-10-24
ATE121089T1 (de) 1995-04-15
ES2071486T3 (es) 1995-06-16
HUT68915A (en) 1995-08-28
RU2110519C1 (ru) 1998-05-10
YU5592A (sh) 1994-11-15
OA09807A (fr) 1994-04-15
MA22392A1 (fr) 1992-10-01
EP0609210B1 (fr) 1995-04-12
US6319926B1 (en) 2001-11-20
PL166976B1 (pl) 1995-07-31
IE920126A1 (en) 1992-07-29
CA2099782A1 (fr) 1992-07-18
DE69202060T2 (de) 1995-10-26
IL100677A (en) 1995-11-27
FR2671800A1 (fr) 1992-07-24
EP0609210A4 (fr) 1993-09-17
US7381724B2 (en) 2008-06-03
NZ241313A (en) 1993-03-26

Similar Documents

Publication Publication Date Title
FI933248A (fi) Optiskt aktiva 5h-pyrrolo(3,4-b)pyrazinderat, dess framstaellning och farmaceutiska kompositioner innehaollande detta
MX9203481A (es) Formulaciones.
DE69101931D1 (de) Pharmazeutische Zusammensetzung.
DE68911473D1 (de) Arzneimittelformulierungen.
DK0585252T3 (da) Farmaceutiske formuleringer
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777A0 (fi) Farmaseuttinen ainekoostumus
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
MA22220A1 (fr) Formulations gelifiees
FI882968A0 (fi) Dryckberedare och distributionsanordning foer hett vatten.
MX9200622A (es) Composicion farmaceutica
UA26064A1 (uk) Фармацевтичhа композиція
IT9020144A0 (it) Composizione farmaceutica contenente egf
FI933477A0 (fi) Monohydrat av ett dinatriumsalt av 4-klorfenyltiometylenbisfosfonsyra,dess framstaellning och farmaceutiska kompositioner innehaollande detta
FI895268A0 (fi) Optiskt aktiva bensoxaziner och bensotiaziner och foerfarande foer deras stereospecifik framstaellning.
MX9204183A (es) Formulacion de prostagladina e1
FI923371A0 (fi) En farmaceutisk formulation.
FI920758A0 (fi) Komposition och dess anvaendning saosom biocid.
FI930695A0 (fi) Torsionsfjaeder och en reblerbar faestanordning foer en stol som anvaenderen dylik fjaeder
NO306381B1 (no) Farmasöytisk ampulle
KR930702987A (ko) 구충활성제 배합물
FI910773A (fi) Farmaceutisk komposition innehaollande ett episialo-kolhydratkomplex.
FI930967A (fi) Substituerade 6,7-dihydroimidazo(1,5,4-ef)(1,5)bensodiazepin-6-oner, deras framstaellning och farmaceutiska kompositioner
FI923161A (fi) Optiskt aktiva isoindolinderivat, deras framstaellning och anvaendning
FI883008A (fi) 8 -acylaminoergolin, dess framstaellning och farmaceutiska kompositioner innehaollande detsamma.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: SEPRACOR INC.

Free format text: SEPRACOR INC.